Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma

Sameer H. Patel MD, Peter J. Kneuertz MD, Maria Delgado MD, David A. Kooby MD, Charles A. Staley III MD, Bassel F. El-Rayes MD, John S. Kauh MD, Juan M. Sarmiento MD, Steven Hanish MD, Cynthia Cohen MD, Alton B. Farris III MD, Shishir K. Maithel MD

Hepatobiliary Tumors

Download citation

Back

Add this article to your Personal Archive

Email this page to a friend

Add a comment Your name
Your email address
Your website Optional
Your comment
What does the image say?

0 comment(s)

NEW UPDATE DECEMBER 2012

Effective January 2013, there will be a processing fee of $50 USD for each initial new submission of an Annals article, excluding editorials. Submitted new manuscripts will not enter the review process until the submission fee has been paid. . There will be no processing fee associated with resubmitted manuscripts.

HIGHLIGHTED VIDEO OF THE MONTH

Lymphatic Mapping and Sentinel Node Biopsy in the Colonic Mesentery by Natural Orifice Transluminal Endoscopic Surgery (NOTES) by R. A. Cahill MD, FRCS, S. Perretta MD, J. Leroy MD, B. Dallemagne MD, and J. Marescaux MD, FRCS, FACS. Annals of Surgical Oncology. Volume 15, Number 10, DOI: 10.1245/s10434-008-9952-8